Response to letter to the editor Re: comment on "Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration"

Graefes Arch Clin Exp Ophthalmol. 2024 May 13. doi: 10.1007/s00417-024-06516-8. Online ahead of print.

Authors

Maiko Maruyama-Inoue¹, Jacob Yuhang Chin², Kazuaki Kadonosono³

Affiliations

¹ Department of Ophthalmology, Yokohama City University Medical Center, 4-57 Urafune-Cho, Minami-Ku, Yokohama, Kanagawa, 232-0024, Japan. maicoo@urahp.yokohama-cu.ac.jp.
² National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.
³ Department of Ophthalmology, Yokohama City University Medical Center, 4-57 Urafune-Cho, Minami-Ku, Yokohama, Kanagawa, 232-0024, Japan.

PMID: 38739167
DOI: 10.1007/s00417-024-06516-8

No abstract available

Publication types

Letter